Applied BioCode Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	434.79	464.79	605.96	413.19	831.32	646.07
Short-Term Investments	107.68	104.8	251.53	191.62	-	-
Cash & Short-Term Investments	542.48	569.59	857.49	604.82	831.32	646.07
Cash Growth	-31.40%	-33.58%	41.78%	-27.25%	28.67%	-23.80%
Receivables	200.58	121.98	45.02	51.04	70.81	67.81
Inventory	192.85	156.29	190.07	174.97	106.68	101.37
Other Current Assets	11.45	10.6	11.71	6.53	5.48	11.2
Total Current Assets	947.35	858.46	1,104	837.36	1,014	826.45
Property, Plant & Equipment	132.71	144.53	98.79	131.14	169.62	162.77
Other Intangible Assets	0.04	0.09	1.8	6.02	10.38	13.43
Long-Term Deferred Tax Assets	3.03	2.98	3.11	4.5	3.99	3.51
Other Long-Term Assets	6.76	6.65	6.92	14.19	14.18	12.8
Total Assets	1,090	1,013	1,215	993.21	1,212	1,019
Accounts Payable	53.19	15.68	6.44	2.58	8.73	9.43
Accrued Expenses	-	38.44	35.63	32.08	35.06	26.11
Current Portion of Leases	20.21	20.79	17.26	16.35	15.66	14.2
Current Income Taxes Payable	-	5.22	2.53	0.47	1.5	4.18
Current Unearned Revenue	22.02	42.78	54.59	43.25	22.77	1.99
Other Current Liabilities	62.02	3.64	13.38	6.84	3.91	4.05
Total Current Liabilities	157.43	126.55	129.83	101.56	87.63	59.95
Long-Term Leases	35.63	38.77	2.27	18.08	33.45	44.56
Long-Term Unearned Revenue	218.3	201.2	200.87	208.08	271.33	7.99
Long-Term Deferred Tax Liabilities	3.03	2.98	3.11	4.5	3.99	3.51
Total Liabilities	414.4	369.49	336.07	332.22	396.38	116.01
Common Stock	1,028	1,028	1,028	817.68	817.63	817.29
Additional Paid-In Capital	37.85	37.22	272.28	43.81	359.24	351.58
Retained Earnings	-396.83	-417.81	-453.97	-193.16	-349.93	-165.2
Comprehensive Income & Other	6.29	-4.31	32.65	-7.34	-10.88	-100.71
Shareholders' Equity	675.5	643.22	878.83	660.99	816.07	902.96
Total Liabilities & Equity	1,090	1,013	1,215	993.21	1,212	1,019
Total Debt	55.83	59.56	19.52	34.43	49.11	58.76
Net Cash (Debt)	486.64	510.03	837.96	570.39	782.21	587.31
Net Cash Growth	-36.90%	-39.13%	46.91%	-27.08%	33.18%	-25.32%
Net Cash Per Share	4.73	4.96	9.25	6.98	9.57	7.19
Filing Date Shares Outstanding	102.82	102.81	102.79	81.77	81.76	81.73
Total Common Shares Outstanding	102.82	102.81	102.79	81.77	81.76	81.73
Working Capital	789.92	731.92	974.46	735.8	926.66	766.5
Book Value Per Share	6.57	6.26	8.55	8.08	9.98	11.05
Tangible Book Value	675.46	643.13	877.03	654.97	805.69	889.52
Tangible Book Value Per Share	6.57	6.26	8.53	8.01	9.85	10.88
Machinery	-	84.49	78.54	70.92	67.91	91.96
Construction In Progress	-	-	-	1.4	17.9	1.01
Leasehold Improvements	-	72.34	75.3	70.79	52.29	46.71